<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36180106</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>CD4<sup>+</sup> T-cell cooperation promoted pathogenic function of activated na&#xef;ve B cells of patients with SLE.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000739</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2022-000739</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To explore cooperation between activated na&#xef;ve (aNAV) B cells and CD4<sup>+</sup> T cells in the pathogenesis of SLE through autoantibody production, T-cell differentiation and inflammatory cytokine secretion.</AbstractText><AbstractText Label="METHODS">Peripheral blood mononuclear cell samples were obtained from 31 patients with SLE and used to characterise phenotype of aNAV B cells (n=14) and measured the phosphorylation of B-cell receptor (BCR) signalling molecules (n=5). Upregulation of T-cell costimulatory molecules after BCR and toll-like receptor (TLR)-7/TLR-8 stimulation was detected in cells from four subjects. To explore the role of these cells in SLE pathogenesis via T cell-dependent mechanisms, four subjects were analysed to detect the promotion of CD4<sup>+</sup> T-cell activation and antibody-secreting cell (ASC) differentiation after CD4<sup>+</sup> T-cell-B-cell cocultures. The aNAV B cells from four patients were used to assess cytokine secretion.</AbstractText><AbstractText Label="RESULTS">The aNAV B cells of patients with SLE had increased expression of surface CD40, HLA-DR and interleukin-21 receptor (IL-21R) and FCRL5 molecules. With BCR stimulation, these cells greatly increased PLC&#x3b3;2 phosphorylation. Integrated BCR and TLR-7/TLR-8 signals induced overexpression of CD40, CD86, IL-21R and HLA-DR on lupus aNAV B cells. In T-cell-B-cell cocultures, lupus aNAV B cells (with upregulated costimulatory molecules) promoted CD4<sup>+</sup> T-cell proliferation and polarisation toward effector Th<sub>2</sub> and Th<sub>17</sub> cells. Importantly, in this coculture system, CD4<sup>+</sup> T-cell signals enhanced aNAV B-cell differentiation into auto-ASCs and produced anti-DNA antibodies. The interaction between CD4<sup>+</sup> T cell and aNAV B cell increased production of inflammatory cytokines (IL-6, IL-8 and IL-23).</AbstractText><AbstractText Label="CONCLUSION">Cooperation between aNAV B cells and CD4<sup>+</sup> T cells contributed to SLE pathogenesis by promoting both differentiation of pathogenic T cells (Th<sub>2</sub> and Th<sub>17</sub>) and autoantibody secretion.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wangriatisak</LastName><ForeName>Kittikorn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6642-076X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kochayoo</LastName><ForeName>Piyawan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thawornpan</LastName><ForeName>Pongsakorn</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leepiyasakulchai</LastName><ForeName>Chaniya</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suangtamai</LastName><ForeName>Thanitta</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngamjanyaporn</LastName><ForeName>Pintip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7948-1748</Identifier><AffiliationInfo><Affiliation>Division of Allergy, Immunology and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khowawisetsut</LastName><ForeName>Ladawan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Microparticle and Exosome in Diseases, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaenam</LastName><ForeName>Prasong</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center of Standardization and Product Validation, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisitkun</LastName><ForeName>Prapaporn</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Medicine Program, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chootong</LastName><ForeName>Patchanee</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6642-076X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand pchooton@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053759">Interleukin-23</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016209">Interleukin-8</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011947">Receptors, Antigen, B-Cell</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051199">Toll-Like Receptor 7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051200">Toll-Like Receptor 8</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.4.3</RegistryNumber><NameOfSubstance UI="D051966">Phospholipase C gamma</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000974" MajorTopicYN="N">Antibodies, Antinuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006684" MajorTopicYN="N">HLA-DR Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053759" MajorTopicYN="N">Interleukin-23</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016209" MajorTopicYN="N">Interleukin-8</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051966" MajorTopicYN="N">Phospholipase C gamma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011947" MajorTopicYN="N">Receptors, Antigen, B-Cell</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="Y">T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051199" MajorTopicYN="N">Toll-Like Receptor 7</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051200" MajorTopicYN="N">Toll-Like Receptor 8</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B-Lymphocytes</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">lupus erythematosus, systemic</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>30</Day><Hour>20</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36180106</ArticleId><ArticleId IdType="pmc">PMC9528597</ArticleId><ArticleId IdType="doi">10.1136/lupus-2022-000739</ArticleId><ArticleId IdType="pii">9/1/e000739</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol 2012;24:651&#x2013;7. 10.1016/j.coi.2012.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2012.10.004</ArticleId><ArticleId IdType="pmc">PMC3508331</ArticleId><ArticleId IdType="pubmed">23131610</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003;56:481&#x2013;90. 10.1136/jcp.56.7.481</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.56.7.481</ArticleId><ArticleId IdType="pmc">PMC1769989</ArticleId><ArticleId IdType="pubmed">12835292</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;rner T, Giesecke C, Lipsky PE. Mechanisms of B cell autoimmunity in SLE. Arthritis Res Ther 2011;13:243. 10.1186/ar3433</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3433</ArticleId><ArticleId IdType="pmc">PMC3308063</ArticleId><ArticleId IdType="pubmed">22078750</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashi E, Wang Y, Diamond B. The role of B cells in lupus pathogenesis. Int J Biochem Cell Biol 2010;42:543&#x2013;50. 10.1016/j.biocel.2009.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2009.10.011</ArticleId><ArticleId IdType="pmc">PMC2835836</ArticleId><ArticleId IdType="pubmed">19850148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo NC, Rao KVS, Natarajan K. Cd80 expression is induced on activated B cells following stimulation by CD86. Scand J Immunol 2002;55:577&#x2013;84. 10.1046/j.1365-3083.2002.01093.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-3083.2002.01093.x</ArticleId><ArticleId IdType="pubmed">12028560</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai-Mehta A, Lu L, Ramsey-Goldman R, et al. . Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996;97:2063&#x2013;73. 10.1172/JCI118643</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118643</ArticleId><ArticleId IdType="pmc">PMC507281</ArticleId><ArticleId IdType="pubmed">8621796</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton JA, Hsu H-C, Mountz JD. Autoreactive B cells in SLE, villains or innocent bystanders? Immunol Rev 2019;292:120&#x2013;38. 10.1111/imr.12815</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12815</ArticleId><ArticleId IdType="pmc">PMC6935412</ArticleId><ArticleId IdType="pubmed">31631359</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward JM, Ratliff ML, Dozmorov MG, et al. . Human effector B lymphocytes express ARID3a and secrete interferon alpha. J Autoimmun 2016;75:130&#x2013;40. 10.1016/j.jaut.2016.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.08.003</ArticleId><ArticleId IdType="pmc">PMC5134920</ArticleId><ArticleId IdType="pubmed">27522115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton JA, Wu Q, Yang P, et al. . Cutting edge: intracellular IFN-&#x3b2; and distinct type I IFN expression patterns in circulating systemic lupus erythematosus B cells. J Immunol 2018;201:2203&#x2013;8. 10.4049/jimmunol.1800791</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800791</ArticleId><ArticleId IdType="pmc">PMC6230322</ArticleId><ArticleId IdType="pubmed">30201809</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris DP, Haynes L, Sayles PC, et al. . Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000;1:475&#x2013;82. 10.1038/82717</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/82717</ArticleId><ArticleId IdType="pubmed">11101868</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Ivanov II, Spolski R, Min R, et al. . IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8:967&#x2013;74. 10.1038/ni1488</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1488</ArticleId><ArticleId IdType="pubmed">17581537</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita R, Schmitt N, Bentebibel S-E, et al. . Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011;34:108&#x2013;21. 10.1016/j.immuni.2010.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.12.012</ArticleId><ArticleId IdType="pmc">PMC3046815</ArticleId><ArticleId IdType="pubmed">21215658</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabry A, Elbasyouni SR, Sheashaa HA, et al. . Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis. Int Urol Nephrol 2006;38:731&#x2013;7. 10.1007/s11255-006-0047-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-006-0047-9</ArticleId><ArticleId IdType="pubmed">17260180</ArticleId></ArticleIdList></Reference><Reference><Citation>Linker-Israeli M, Deans RJ, Wallace DJ, et al. . Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991;147:117&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">2051017</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabay C, Cakir N, Moral F, et al. . Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 1997;24:303&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9034987</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob N, Stohl W. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity 2010;43:84&#x2013;97. 10.3109/08916930903374600</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916930903374600</ArticleId><ArticleId IdType="pmc">PMC2809122</ArticleId><ArticleId IdType="pubmed">20014977</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Sun L, Jiang T, et al. . TNF&#x3b1; promotes Th17 cell differentiation through IL-6 and IL-1&#x3b2; produced by monocytes in rheumatoid arthritis. J Immunol Res 2014;2014:385352. 10.1155/2014/385352</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/385352</ArticleId><ArticleId IdType="pmc">PMC4243768</ArticleId><ArticleId IdType="pubmed">25436214</ArticleId></ArticleIdList></Reference><Reference><Citation>Wangriatisak K, Thanadetsuntorn C, Krittayapoositpot T, et al. . The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients. Arthritis Res Ther 2021;23:179. 10.1186/s13075-021-02557-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02557-0</ArticleId><ArticleId IdType="pmc">PMC8259008</ArticleId><ArticleId IdType="pubmed">34229724</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipton CM, Fucile CF, Darce J, et al. . Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol 2015;16:755&#x2013;65. 10.1038/ni.3175</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3175</ArticleId><ArticleId IdType="pmc">PMC4512288</ArticleId><ArticleId IdType="pubmed">26006014</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks SA, Cashman KS, Zumaquero E, et al. . Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 2018;49:725&#x2013;39. 10.1016/j.immuni.2018.08.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.08.015</ArticleId><ArticleId IdType="pmc">PMC6217820</ArticleId><ArticleId IdType="pubmed">30314758</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharer CD, Blalock EL, Barwick BG, et al. . ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in na&#xef;ve SLE B cells. Sci Rep 2016;6:27030. 10.1038/srep27030</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27030</ArticleId><ArticleId IdType="pmc">PMC4888756</ArticleId><ArticleId IdType="pubmed">27249108</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues Fonseca A, Felix Rodrigues MC, Sztajnbok FR, et al. . Comparison among ACR1997, SLICC and the new EULAR/ACR classification criteria in childhood-onset systemic lupus erythematosus. Adv Rheumatol 2019;59:20. 10.1186/s42358-019-0062-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42358-019-0062-z</ArticleId><ArticleId IdType="pubmed">31092290</ArticleId></ArticleIdList></Reference><Reference><Citation>Batu ED, Akca UK, K&#x131;saarslan AP, et al. . The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus. J Rheumatol 2021;48:907&#x2013;14. 10.3899/jrheum.200871</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.200871</ArticleId><ArticleId IdType="pubmed">33191281</ArticleId></ArticleIdList></Reference><Reference><Citation>Dement-Brown J, Newton CS, Ise T, et al. . Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes. J Leukoc Biol 2012;91:59&#x2013;67. 10.1189/jlb.0211096</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0211096</ArticleId><ArticleId IdType="pubmed">22028333</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis RS, Wang YH, Kubagawa H, et al. . Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci U S A 2001;98:9772&#x2013;7. 10.1073/pnas.171308498</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.171308498</ArticleId><ArticleId IdType="pmc">PMC55528</ArticleId><ArticleId IdType="pubmed">11493702</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersone L, Edner NM, Ovcinnikovs V, et al. . T cell/B cell collaboration and autoimmunity: an intimate relationship. Front Immunol 2018;9:9. 10.3389/fimmu.2018.01941</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01941</ArticleId><ArticleId IdType="pmc">PMC6119692</ArticleId><ArticleId IdType="pubmed">30210496</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumaquero E, Stone SL, Scharer CD, et al. . IFN&#x3b3; induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. Elife 2019;8. doi:10.7554/eLife.41641. [Epub ahead of print: 15 05 2019].</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.41641</ArticleId><ArticleId IdType="pmc">PMC6544433</ArticleId><ArticleId IdType="pubmed">31090539</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkiel S, Barlev AN, Atisha-Fregoso Y, et al. . Plasma cell differentiation pathways in systemic lupus erythematosus. Front Immunol 2018;9:427. 10.3389/fimmu.2018.00427</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00427</ArticleId><ArticleId IdType="pmc">PMC5845388</ArticleId><ArticleId IdType="pubmed">29556239</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry CT, Liu X, Myles A, et al. . BCR-Induced Ca2+ Signals Dynamically Tune Survival, Metabolic Reprogramming, and Proliferation of Naive B Cells. Cell Rep 2020;31:107474. 10.1016/j.celrep.2020.03.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.03.038</ArticleId><ArticleId IdType="pmc">PMC7301411</ArticleId><ArticleId IdType="pubmed">32294437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Gao J, Kang J, et al. . B cells in rheumatoid Arthritis&#xff1a;Pathogenic mechanisms and treatment prospects. Front Immunol 2021;12:750753. 10.3389/fimmu.2021.750753</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.750753</ArticleId><ArticleId IdType="pmc">PMC8505880</ArticleId><ArticleId IdType="pubmed">34650569</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M-F, Wang C-R. Increased Th17 cells in flow cytometer-sorted CD45RO-positive memory CD4 T cells from patients with systemic lupus erythematosus. Lupus Sci Med 2014;1:e000062. 10.1136/lupus-2014-000062</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2014-000062</ArticleId><ArticleId IdType="pmc">PMC4271411</ArticleId><ArticleId IdType="pubmed">25553252</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuliasih Y, Rahmawati LD, Putri RM. Th17/Treg ratio and disease activity in systemic lupus erythematosus. Caspian J Intern Med 2019;10:65&#x2013;72. 10.22088/cjim.10.1.65</Citation><ArticleIdList><ArticleId IdType="doi">10.22088/cjim.10.1.65</ArticleId><ArticleId IdType="pmc">PMC6386323</ArticleId><ArticleId IdType="pubmed">30858943</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappione A, Anolik JH, Pugh-Bernard A, et al. . Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 2005;115:3205&#x2013;16. 10.1172/JCI24179</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI24179</ArticleId><ArticleId IdType="pmc">PMC1242189</ArticleId><ArticleId IdType="pubmed">16211091</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkaya M, Kwak K, Pierce SK. B cell memory: building two walls of protection against pathogens. Nat Rev Immunol 2020;20:229&#x2013;38. 10.1038/s41577-019-0244-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0244-2</ArticleId><ArticleId IdType="pmc">PMC7223087</ArticleId><ArticleId IdType="pubmed">31836872</ArticleId></ArticleIdList></Reference><Reference><Citation>Duddy ME, Alter A, Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation? J Immunol 2004;172:3422&#x2013;7. 10.4049/jimmunol.172.6.3422</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.6.3422</ArticleId><ArticleId IdType="pubmed">15004141</ArticleId></ArticleIdList></Reference><Reference><Citation>Arkatkar T, Du SW, Jacobs HM, et al. . B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity. J Exp Med 2017;214:3207&#x2013;17. 10.1084/jem.20170580</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20170580</ArticleId><ArticleId IdType="pmc">PMC5679179</ArticleId><ArticleId IdType="pubmed">28899868</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaat RM, Mohamed SF, Bassyouni IH, et al. . Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine 2015;72:146&#x2013;53. 10.1016/j.cyto.2014.12.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.12.027</ArticleId><ArticleId IdType="pubmed">25647269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruchakorn N, Ngamjanyaporn P, Suangtamai T, et al. . Performance of cytokine models in predicting SLE activity. Arthritis Res Ther 2019;21:287. 10.1186/s13075-019-2029-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-2029-1</ArticleId><ArticleId IdType="pmc">PMC6915901</ArticleId><ArticleId IdType="pubmed">31842967</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy EM, Smith S, Lee RZ, et al. . The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients. Rheumatology 2014;53:1586&#x2013;94. 10.1093/rheumatology/ket428</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ket428</ArticleId><ArticleId IdType="pubmed">24706988</ArticleId></ArticleIdList></Reference><Reference><Citation>Oke V, Gunnarsson I, Dorschner J, et al. . High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus. Arthritis Res Ther 2019;21:107. 10.1186/s13075-019-1878-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-1878-y</ArticleId><ArticleId IdType="pmc">PMC6489203</ArticleId><ArticleId IdType="pubmed">31036046</ArticleId></ArticleIdList></Reference><Reference><Citation>An Q, Yan W, Zhao Y, et al. . Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, IL-10 and MCP-1 in rheumatoid arthritis. Int Immunopharmacol 2018;65:119&#x2013;28. 10.1016/j.intimp.2018.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2018.09.011</ArticleId><ArticleId IdType="pubmed">30312880</ArticleId></ArticleIdList></Reference><Reference><Citation>Revu S, Wu J, Henkel M, et al. . Il-23 and IL-1&#x3b2; drive human Th17 cell differentiation and metabolic reprogramming in absence of CD28 costimulation. Cell Rep 2018;22:2642&#x2013;53. 10.1016/j.celrep.2018.02.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.02.044</ArticleId><ArticleId IdType="pmc">PMC5884137</ArticleId><ArticleId IdType="pubmed">29514093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai H, He F, Tsokos GC, et al. . Il-23 limits the production of IL-2 and promotes autoimmunity in lupus. J Immunol 2017;199:903&#x2013;10. 10.4049/jimmunol.1700418</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700418</ArticleId><ArticleId IdType="pmc">PMC5526729</ArticleId><ArticleId IdType="pubmed">28646040</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrada AA, Escobedo N, Iruretagoyena M, et al. . Innate immune cells' contribution to systemic lupus erythematosus. Front Immunol 2019;10:772. 10.3389/fimmu.2019.00772</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00772</ArticleId><ArticleId IdType="pmc">PMC6476281</ArticleId><ArticleId IdType="pubmed">31037070</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>